Source: International Congress 2016 – Respiratory nursing research: opening new perspectives on patient experiences
Disease area: Interstitial lung diseases



Rating:

Share or cite this content

Citations should be made in the following way:
Dorthe Overgaard (Køge, Denmark), Dorthe Overgaard, Gudrun Kaldan, Kristoffer Marsaa, Thyge Lynghøj Nielsen, Saher Burkan Shaker, Ingrid Egerod. The lived experience of idiopatic pulmonary fibrosis: A qualitative study. Eur Respir J 2016; 48: Suppl. 60, 291

Member's Comments

No comment yet.

Related content which might interest you: The burden of idiopathic pulmonary fibrosis reported by patients and carers in Ireland Source: International Congress 2015 – IPF: clinical aspects Year: 2015 Quality of life of patients with idiopathic pulmonary fibrosis (IPF) - What can the Australian IPF registry tell us? Source: International Congress 2015 – IPF: clinical aspects II Year: 2015 A longitudinal study of anxiety and depression in idiopathic pulmonary fibrosis (IPF) Source: Annual Congress 2013 –Diffuse pulmonary fibrosis Year: 2013 Real life patient experience of pirfenidone in a regional interstitial lung disease clinic Source: International Congress 2015 – IPF: from bench to bedside Year: 2015 Understanding patients’ experience of living with non-cystic fibrosis bronchiectasis Source: Annual Congress 2013 –Aspects of physiotherapy in various clinical conditions and settings Year: 2013 Item generation for a patient reported outcome measure (PRoM) in idiopathic pulmonary fibrosis (IPF): Application of consensus methods Source: International Congress 2015 – IPF: clinical aspects Year: 2015 Sleep quality among patients with idiopathic pulmonary fibrosis Source: International Congress 2015 – Interstitial lung diseases II Year: 2015 Health status & impact of living with idiopathic pulmonary fibrosis (IPF): UK & Ireland Delphi survey Source: International Congress 2016 – IPF clinical Year: 2016 Onset of symptoms in idiopathic pulmonary fibrosis: A case-control study Source: International Congress 2016 – IPF: from pathogenesis to treatment I Year: 2016 Quality of life of idiopathic pulmonary fibrosis patients Source: International Congress 2017 – IPF: from the bench to the bedside Year: 2017 Quality of life in patients with idiopathic pulmonary fibrosis Source: Eur Respir J 2005; 26: Suppl. 49, 30s Year: 2005 Real life experience with nintedanib in patients with idiopathic pulmonary fibrosis Source: International Congress 2016 – IPF: from pathogenesis to treatment II Year: 2016 The development of a measure to better understand patient experiences with pirfenidone and nintedanib for the treatment of idiopathic pulmonary fibrosis (IPF) Source: International Congress 2016 – IPF: from pathogenesis to treatment I Year: 2016 Clinical outcomes of patients with idiopathic pulmonary fibrosis in clinical practice: Follow-up results of the INSIGHTS-IPF registry Source: International Congress 2015 – IPF: clinical aspects II Year: 2015 Assessing quality of life of idiopathic pulmonary fibrosis patients: the INSTAGE study Source: Breathe, 15 (2) 144; 10.1183/20734735.0016-2019 Year: 2019 Idiopathic pulmonary fibrosis: recent milestones in disease management Source: Eur Respir Rev 2012; 21: 140 Year: 2012 Pirfenidone treatment in idiopathic pulmonary fibrosis: An Italian case series Source: Annual Congress 2013 –Idiopathic pulmonary fibrosis: clinical view Year: 2013 Clinical characteristics and survival in patients with idiopathic pulmonary fibrosis with and without associated emphysema Source: Annual Congress 2013 –Idiopathic pulmonary fibrosis: clinical view Year: 2013 Validation of GAP score in Danish patients diagnosed with idiopathic pulmonary fibrosis Source: Annual Congress 2013 –Diffuse parenchymal lung disease II Year: 2013 Pirfenidone in idiopathic pulmonary fibrosis - Real life experience from a german tertiary referral centre for interstitial lung diseases Source: Annual Congress 2013 –Diffuse pulmonary fibrosis Year: 2013